UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bilateral Sacrospineous Colposupension in the treatment of female genital prolapse: Risk-Benefit Considerations and Six Months Follow-up

Pelviperineology, 2020-09, Vol.39 (3), p.85-89

2020

Volltextzugriff (PDF)

Abstract P1-06-04: Simplified histological grading of breast carcinoma – potential for improved concordance and consistency in breast cancer grading?

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-06-04

2018

Volltextzugriff (PDF)

Abstract PD4-11: Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD4-11-PD4-11

2018

Volltextzugriff (PDF)

Abstract P1-06-02: Comparative survival analysis of multiparametric tests in the TEAM pathology study: What to do when molecular tests disagree?

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-06-02

2018

Volltextzugriff (PDF)

Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.524-524

2017

Volltextzugriff (PDF)

Targeted sequencing in a phase III trial of luminal breast cancer: Identification of novel targets

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.505-505

2017

Volltextzugriff (PDF)

Abstract P2-08-29: Defining a signature of residual risk following endocrine treatment in the tamoxifen and exemestane adjuvant multinational (TEAM) trial

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-08-29

2016

Volltextzugriff (PDF)

Die Kolposuspension mit BSC transischiorektal – 5-Jahres Langzeitergebnisse

Geburtshilfe und Frauenheilkunde, 2014, Vol.74 (S 01)

2014

Volltextzugriff (PDF)

Die Kolposuspension mit BSC direct – Minimal invasiv, maximal effektiv

Geburtshilfe und Frauenheilkunde, 2014, Vol.74 (S 01)

2014

Volltextzugriff (PDF)

Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

British journal of cancer, 2013-10, Vol.109 (9), p.2453-2461

2013

Volltextzugriff (PDF)

Abstract S1-5: PIK3CA mutations are linked to PgR expression: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) pathology study

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.S1-S1-5

2012

Volltextzugriff (PDF)

Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAM

Annals of oncology, 2012-10, Vol.23 (10), p.2566-2572

2012

Volltextzugriff (PDF)

Effects of exemestane and tamoxifen on hormone levels within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) Trial: results of a German substudy

Climacteric : the journal of the International Menopause Society, 2012-10, Vol.15 (5), p.460-466

2012

Volltextzugriff (PDF)

P2-17-02: Increased Progression Free and Overall Survival in Breast Cancer Patients with Menopausal Symptoms or Arthralgia/Myalgia during Adjuvant Treatment with Exemestane or Tamoxifen – Results of the German TEAM Trial

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P2-P2-17-02

2011

Volltextzugriff (PDF)

Increased progression-free and overall survival in patients with breast cancer with menopausal symptoms or arthralgia/myalgia during adjuvant treatment with exemestane or tamoxifen: Results of the German TEAM trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.523-523

2011

Volltextzugriff (PDF)

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

Journal of clinical oncology, 2011-04, Vol.29 (12), p.1531-1538

2011

Volltextzugriff (PDF)

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

The Lancet (British edition), 2011-01, Vol.377 (9762), p.321-331

2011

Volltextzugriff (PDF)

Endometrial effects of exemestane compared to tamoxifen within the Tamoxifen Exemestane Adjuvant Multicenter (TEAM) trial: Results of a prospective gynecological ultrasound substudy

Gynecologic oncology, 2010-12, Vol.119 (3), p.500-505

2010

Volltextzugriff (PDF)

Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries

British journal of surgery, 2010-05, Vol.97 (5), p.671-679

2010

Volltextzugriff (PDF)

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy

Nature medicine, 2010-05, Vol.16 (5), p.565-570

2010

Volltextzugriff (PDF)

Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy

Annals of oncology, 2009-07, Vol.20 (7), p.1203-1209

2009

Volltextzugriff (PDF)

The effect of exemestane or tamoxifen on markers of bone turnover: Results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial

Breast (Edinburgh), 2009-06, Vol.18 (3), p.159-164

2009

Volltextzugriff (PDF)

Adenovirus-mediated Thymidine Kinase Gene Therapy Induces Apoptosis in Human Epithelial Ovarian Cancer Cells and Damages PARP-1

In vivo (Athens), 2009-01, Vol.23 (1), p.77

Kieback, D G

2009

Volltextzugriff (PDF)

Adenovirus-mediated Thymidine Kinase Gene Therapy and Coxsackie Adenovirus Receptor Expression in Ovarian Cancer Cells

Cancer genomics & proteomics, 2008-11, Vol.5 (6), p.311

Kieback, D G

2008

Volltextzugriff (PDF)

MECHANISM OF ACTION AND DURATION OF TRANSLATION OF THE THYMIDINE KINASE GENE IN ADENOVIRUS-MEDIATED GENE THERAPY OF OVARIAN CANCER

Anticancer research, 2008-10, Vol.28 (5C)

2008

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Englisch
(127)
Deutsch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bilateral Sacrospineous Colposupension in the treatment of female genital prolapse: Risk-Benefit Considerations and Six Months Follow-up

Abstract P1-06-04: Simplified histological grading of breast carcinoma – potential for improved concordance and consistency in breast cancer grading?

Abstract PD4-11: Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers

Abstract P1-06-02: Comparative survival analysis of multiparametric tests in the TEAM pathology study: What to do when molecular tests disagree?

Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers

Targeted sequencing in a phase III trial of luminal breast cancer: Identification of novel targets

Abstract P2-08-29: Defining a signature of residual risk following endocrine treatment in the tamoxifen and exemestane adjuvant multinational (TEAM) trial

Die Kolposuspension mit BSC transischiorektal – 5-Jahres Langzeitergebnisse

Die Kolposuspension mit BSC direct – Minimal invasiv, maximal effektiv

Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

Abstract S1-5: PIK3CA mutations are linked to PgR expression: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) pathology study

Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAM

Effects of exemestane and tamoxifen on hormone levels within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) Trial: results of a German substudy

P2-17-02: Increased Progression Free and Overall Survival in Breast Cancer Patients with Menopausal Symptoms or Arthralgia/Myalgia during Adjuvant Treatment with Exemestane or Tamoxifen – Results of the German TEAM Trial

Increased progression-free and overall survival in patients with breast cancer with menopausal symptoms or arthralgia/myalgia during adjuvant treatment with exemestane or tamoxifen: Results of the German TEAM trial

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

Endometrial effects of exemestane compared to tamoxifen within the Tamoxifen Exemestane Adjuvant Multicenter (TEAM) trial: Results of a prospective gynecological ultrasound substudy

Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy

Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy

The effect of exemestane or tamoxifen on markers of bone turnover: Results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial

Adenovirus-mediated Thymidine Kinase Gene Therapy Induces Apoptosis in Human Epithelial Ovarian Cancer Cells and Damages PARP-1

Adenovirus-mediated Thymidine Kinase Gene Therapy and Coxsackie Adenovirus Receptor Expression in Ovarian Cancer Cells

MECHANISM OF ACTION AND DURATION OF TRANSLATION OF THE THYMIDINE KINASE GENE IN ADENOVIRUS-MEDIATED GENE THERAPY OF OVARIAN CANCER

Suchergebnisse filtern